Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $83

Benzinga · 2d ago
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $77 to $83.